Global Autologous Cell Therapy Market Share

Statistics for the 2023 & 2024 Global Autologous Cell Therapy market share, created by Mordor Intelligence™ Industry Reports. Global Autologous Cell Therapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Autologous Cell Therapy Industry

The autologous cell therapy market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market.  And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Vericel Corporation, Pharmicell Co., Inc., Holostem Terapie Avanzate S.r.l., Lineage Cell Therapeutics, Inc., and Opexa Therapeutics.

Autologous Cell Therapy Market Leaders

  1. Vericel Corporation

  2. Pharmicell Co., Inc.

  3. Holostem Terapie Avanzate S.r.l.

  4. Opexa Therapeutics

  5. Lineage Cell Therapeutics, Inc.

*Disclaimer: Major Players sorted in no particular order

Autologous - MC.jpg

Autologous Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)